Betaferon Treatment and Exercise Data Gathering IN Early MS.
Phase of Trial: Phase IV
Latest Information Update: 23 Jun 2015
At a glance
- Drugs Interferon beta-1b (Primary)
- Indications Multiple sclerosis
- Focus Therapeutic Use
- Acronyms BEGIN
- Sponsors Bayer
- 23 Jun 2015 Follow-up at 2-years (n=220 CIS+346 RRMS patients),results presented at the 1st Congress of the European Academy of Neurology.
- 10 Jun 2011 Actual end date (Mar 2011) added as reported by ClinicalTrials.gov.
- 10 Jun 2011 Status changed from recruiting to completed as reported by ClinicalTrials.gov.